2026 · Collaboration
Research collaborations
H. Lee Moffitt Cancer Center and Research Institute
Jupiter Biomedical Research, Inc. has entered a research collaboration with the H. Lee Moffitt Cancer Center and Research Institute, Inc., a National Cancer Institute-designated, comprehensive cancer center, to evaluate the efficacy and mechanism of action of its lead clinical candidate, JBR-102, across multiple solid tumor cancer cell types. This collaboration has helped to accelerate JBR's innovative therapeutic development capabilities with Moffitt's world-class cancer research and clinical expertise to advance novel treatment options for patients in need
Cleveland Clinic Florida Research & Innovation Center (FRIC)
Jupiter Biomedical Research, Inc. has entered a research collaboration with the Cleveland Clinic's Florida Research & Innovation Center (FRIC) to evaluate the efficacy and mechanism of action of its lead antiviral candidate, JBR-201, across multiple types of pathogenic viruses. The FRIC collaboration will align JBR’s innovative oral therapeutic development capabilities with the Cleveland Clinic's Global Center for Pathogen and Human Health Research providing a focus on basic and translational research with a goal to advance a novel antiviral therapy to treat patients suffering from challenging diseases.